J. B. Chemicals & Pharmaceuticals Limited (JBCHEPHARM.NS)
INR 1934.75
(4.25%)
INR 1934.75
(4.25%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 7.6 Billion | 6.25 Billion | 1.7 Billion | 3.14 Billion | 2.75 Billion | 1.93 Billion |
| Net Income | 5.52 Billion | 5.55 Billion | 5.04 Billion | 5.96 Billion | 3.48 Billion | 2.86 Billion |
| Depreciation & Amortization | 1.38 Billion | 1.14 Billion | 726.59 Million | 686.65 Million | 663.22 Million | 556.42 Million |
| Deferred income taxes | - | -1.14 Billion | -1.68 Billion | - | - | - |
| Stock-based compensation | 419.66 Million | 693.7 Million | 626.5 Million | - | - | - |
| Change in working capital | -56.3 Million | -299.2 Million | -3.02 Billion | -942.09 Million | 93.23 Million | -519.53 Million |
| Other non-cash items | 3.57 Billion | 311.9 Million | 10.32 Million | -2.56 Billion | -1.49 Billion | -976.04 Million |
| Investing Cash Flow | -4.07 Billion | -9.61 Billion | 23.19 Million | -2.3 Billion | 243.02 Million | -268.89 Million |
| Investments in PPE | -2.61 Billion | -7.64 Billion | -7.06 Billion | -477.73 Million | -729.67 Million | -483.44 Million |
| Acquisitions | 9.7 Million | 1.99 Billion | -7 Billion | -85 Million | 65.54 Million | 105.01 Million |
| Investment purchases | -8.68 Billion | -7.56 Billion | -5.08 Billion | -5.41 Billion | -3.82 Billion | -4.25 Billion |
| Sales/Maturities of investments | 7.21 Billion | 5.57 Billion | 12.08 Billion | 3.16 Billion | 4.73 Billion | 4.35 Billion |
| Other Investing Activities | -2.76 Billion | -1.96 Billion | 7.09 Billion | 498.89 Million | -5.39 Million | 5.8 Million |
| Financing Cash Flow | -3.41 Billion | 3.56 Billion | -1.38 Billion | -874.22 Million | -3.06 Billion | -1.55 Billion |
| Debt repayment | -1.91 Billion | -872.5 Million | -3.27 Million | -3.22 Million | -63.14 Million | -500 Thousand |
| Dividends payments | -1.56 Billion | -1.27 Billion | -1.27 Billion | -732.4 Million | -1.41 Billion | -207.94 Million |
| Common Stock Repurchased | - | 5.68 Billion | - | - | -1.6 Billion | -1.31 Billion |
| Common Stock Issuance | 199.9 Million | 84.8 Million | - | - | -63.14 Million | 500 Thousand |
| Other Financing Activities | -368.1 Million | -55.8 Million | -104.95 Million | -138.6 Million | 83.98 Million | -34.65 Million |
| Accounts receivables | -716 Million | -417.46 Million | -2.92 Billion | -705.98 Million | -114.95 Million | -138.76 Million |
| Accounts payables | 1.38 Billion | 323.49 Million | 528.34 Million | 464.75 Million | 521.06 Million | -285.71 Million |
| Inventory | -720.3 Million | -205.2 Million | -625.14 Million | -700.85 Million | -309.12 Million | -300.26 Million |
| Other working capital | 1.37 Billion | -30 Thousand | - | - | -3.75 Million | 205.21 Million |
| Cash at beginning of period | 788.12 Million | 565.4 Million | 224.73 Million | 257.51 Million | 321.41 Million | 212.42 Million |
| Cash at end of period | 955.4 Million | 769.3 Million | 565.44 Million | 224.73 Million | 257.51 Million | 321.41 Million |
| Capital Expenditure | -2.61 Billion | -7.64 Billion | -7.06 Billion | -477.73 Million | -729.67 Million | -483.44 Million |
| Effect of forex changes on cash | -200 Thousand | 300 Thousand | 10 Thousand | 355 Thousand | -129 Thousand | -231 Thousand |
| Net cash flow / Change in cash | 167.27 Million | 203.9 Million | 340.7 Million | -32.78 Million | -63.89 Million | 108.99 Million |
| Free Cash Flow | 4.99 Billion | -1.39 Billion | -5.36 Billion | 2.67 Billion | 2.02 Billion | 1.44 Billion |
| Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 1.76 Billion | 5.52 Billion | 1.26 Billion | 1.33 Billion | 1.5 Billion | 1.42 Billion |
| Depreciation & Amortization | - | 1.38 Billion | - | 340.3 Million | 321.7 Million | 313.8 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | 419.7 Million | 116.86 Million | 118.6 Million | 77 Million | - |
| Change in working capital | - | -56.3 Million | - | - | - | - |
| Other non-cash items | -1.76 Billion | 3.57 Billion | -1.37 Billion | -1.45 Billion | -1.58 Billion | -1.42 Billion |
| Investing Cash Flow | - | -4.07 Billion | - | - | - | - |
| Investments in PPE | - | -2.61 Billion | - | - | - | - |
| Acquisitions | - | 9.7 Million | - | - | - | - |
| Investment purchases | - | -8.68 Billion | - | - | - | - |
| Sales/Maturities of investments | - | 7.21 Billion | - | - | - | - |
| Other Investing Activities | - | -2.76 Billion | - | - | - | - |
| Financing Cash Flow | - | -3.41 Billion | - | - | - | - |
| Debt repayment | - | -1.91 Billion | - | - | - | - |
| Dividends payments | - | -1.56 Billion | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 199.9 Million | - | - | - | - |
| Other Financing Activities | - | -368.1 Million | - | - | - | - |
| Accounts receivables | - | -716 Million | - | - | - | - |
| Accounts payables | - | 1.38 Billion | - | - | - | - |
| Inventory | - | -720.3 Million | - | - | - | - |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | - | 788.12 Million | - | 932 Million | 211.6 Million | 788.12 Million |
| Cash at end of period | - | 955.4 Million | - | 1.61 Billion | 932 Million | 1.41 Billion |
| Capital Expenditure | - | -2.61 Billion | - | - | - | - |
| Effect of forex changes on cash | - | -200 Thousand | - | - | - | - |
| Net cash flow / Change in cash | - | 167.27 Million | - | 680.6 Million | 720.4 Million | 627.6 Million |
| Free Cash Flow | - | 4.99 Billion | - | 680.6 Million | 720.4 Million | 627.6 Million |
RFG
EQFN
KPIL
ROX
FNR
MITUF